Mr. Howard Marshall Keebler Iii, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 318 E 4th St, Emporium, PA 15834 Phone: 814-486-1191 Fax: 814-486-1195 |
Mr. A Blair Lundberg, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 34 East 4th St, Emporium, PA 15834 Phone: 814-486-3310 Fax: 814-486-0974 |
Mrs. Celine A Huff, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 318 E 4th St, Emporium, PA 15834 Phone: 814-486-1191 Fax: 814-486-1195 |
Thomas Luchs Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 620 E Allegany Ave, Emporium, PA 15834 Phone: 814-486-2007 |
News Archive
Results from a prospective clinical trial showed that a blood test looking at specific biomarkers was able to detect recurrences of lung cancer an average of six months before conventional imaging methods found evidence of recurrence.
President Barack Obama met with Russian President Dmitry Medvedev in Deauville, France, ahead of the G8 summit, ABC News' "Political Punch" blog reports. "The two issued a number of joint statements and agreements on counterterrorism, civil aviation security, visa issues, the Bering Strait region, a joint report assessing 21st Century Missile Challenges, innovation, the rule of law, smart grid partnership, eradicating polio, and medical research," according to the blog.
The artificial sweetener sucralose is a biologically active compound according to an extensive review published by Taylor & Francis in the recent issue of Journal of Toxicology and Environmental Health, Part B: Critical Reviews. "Sucralose, A Synthetic Organochlorine Sweetener: Overview Of Biological Issues" authored by Susan S. Schiffman, PhD, an internationally known sweetener researcher and Kristina I. Rother, MD, MHSc, of the National Institutes of Health (NIH), summarizes the biological properties of sucralose based on hundreds of archival, peer-reviewed scientific journal publications.
Haber, Inc. ("Haber"), (OTC: HABE), a Delaware corporation headquartered in Arlington, Mass., with proprietary technologies in the separations sciences and environmentally friendly processing of gold bearing ores, announced today that it has formed a wholly owned subsidiary incorporated in Delaware called "EMP Diagnostics Inc." ("EDI"). The business of the new company will focus on the application of Haber's Electromolecular Propulsion technology (EMP). EMP is a separation technology that achieves unrivaled molecular separation speeds and has other unique capabilities not attainable with electrophoresis or liquid chromatography.
Participation in elite adult rugby may be associated with changes in brain structure.
› Verified 4 days ago